Andere Sprachen RxSight, Inc.

Aktien

A3CWDW

US78349D1072

RXST

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 15.05.2024			% 5 Tage	% 1. Jan.
64,29 ^USD	+6,78 %		+5,98 %	+59,45 %

07.05.	RXSIGHT, INC. : erhält Kaufen-Rating von Wells Fargo Securities	ZM
07.05.	RXSIGHT, INC. : Needham & Co. bekräftigt seine Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

RxSight Raises $115 Million From Public Offering of Shares	13.05.
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	13.05.
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	13.05.
RxSight, Inc. Announces Pricing of Public Offering of Common Stock	09.05.
RxSight, Inc. Announces Proposed Public Offering of Common Stock	08.05.
RxSight, Inc. Announces Proposed Public Offering of Common Stock	08.05.
RxSight Q1 Adjusted Loss Narrows, Revenue Rises	07.05.
Rxsight Insider Sold Shares Worth $2,405,872, According to a Recent SEC Filing	06.05.
Earnings Flash (RXST) RXSIGHT Posts Q1 Revenue $29.5M, vs. Street Est of $27.6M	06.05.
RxSight, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06.05.
RxSight, Inc. Reports First Quarter 2024 Financial Results	06.05.
RxSight, Inc. Reports First Quarter 2024 Financial Results	06.05.
RxSight, Inc. Increases Earnings Guidance for the Full Year 2024	06.05.
Rxsight Insider Sold Shares Worth $526,913, According to a Recent SEC Filing	02.05.
RxSight, Inc. to Present at the Bank of America Healthcare Conference	01.05.
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024	22.04.
RxSight Launches New Light Adjustable Lens Product	04.04.
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting	04.04.
RxSight, Inc. Announces Commercial Launch of its Newest Light Adjustable Lens??, the LAL+??, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting	04.04.
Rxsight Insider Sold Shares Worth $997,946, According to a Recent SEC Filing	02.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen RxSight, Inc.

Aktien

A3CWDW

US78349D1072

RXST

Andere Sprachen

Filter